Patients often relapse after discharge from acute care because of long waits for outpatient treatment, lack of specialized therapists, out-of-pocket costs, and inadequate social support.
Patients who have anorexia nervosa and are discharged from acute care could benefit from an app specially designed to offset barriers to effective outpatient treatment, according to eating disorder professionals interviewed in a new study published in Frontiers in Digital Health. Their findings suggest that a recovery-focused app might help prevent relapse.
Prior research reports relapse rates of 31% to 52%, with the highest rates during the first 2 months following discharge, the authors wrote.
Patients with anorexia nervosa are typically discharged from treatment centers once they hit their goal weight range, especially in hospital programs, the authors explained. However, although weight restoration and medical stabilization are important goals, research shows that full recovery also involves resolution of behavioral and psychological symptoms.
“Achievement of full recovery in the acute setting is challenging and often not possible,” the authors said. “High-quality outpatient care is imperative to prevent relapse.”
They proposed to develop an app to provide community-based support for persons in recovery from anorexia nervosa, which has the second highest mortality rate of any mental disorder.
Goals of the study were to understand the transition process more fully from acute to outpatient care, examine how eating disorder providers currently use technology in treatment frameworks, and gather feedback from eating disorder professionals on how best to incorporate an app into post–acute care of anorexia nervosa.
The researchers contacted 12 treatment centers from across the United States. Ultimately, 11 eating disorder providers from 7 treatment centers partnered with the research team.
To address the aims of their study, the authors used semistructured interview questions to assess each treatment center’s approach to discharging patients. Five wide-ranging themes emerged:
The most common obstacles to accessing effective outpatient treatment were a shortage of specialized therapists and long wait lists.
Participant input offered much anecdotal evidence on the strengths and weaknesses associated with current postacute treatment. Barriers to high-quality outpatient care included the following:
In addition, participants offered keen insight into strategies that would strengthen support for patients leaving intensive treatment:
Although the present study offered important findings, there were several limitations. Of the participants interviewed, all were White and not Hispanic or Latino. Additionally, of the 11 providers, 8 were female. Finally, thematic analysis was conducted by only 1 rater.
Still, the study researchers and participants alike expressed positive attitudes toward the integration of an app into the post–acute care flow, suggesting its potential benefit as a treatment tool.
“The key to developing quality app-based interventions is engaging individuals who will be most implicated by the intervention: app users and treatment center representatives,” the authors concluded.
Reference
Haas A, Laboe AA, McGinnis C, et. al. Adapting a mobile app to support patients with anorexia nervosa following post-acute care: perspectives from eating disorder treatment center stakeholders. Front Digit Health.Published online May 19, 2023. doi: 10.3389/fdgth.2023.1099718
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More